Intrapartum Azithromycin vs Placebo for Neonatal Sepsis—Reply
In Reply We appreciate the comments by Dr Gu and colleagues about our study that evaluated the effect of oral intrapartum azithromycin vs placebo on neonatal sepsis or death. This double-blind randomized clinical trial of 11 983 birthing parents and their newborns in The Gambia and Burkina Faso found that azithromycin did not reduce neonatal sepsis or mortality, but did reduce the incidence of several secondary end points, such as mastitis in birthing parents and skin infections in neonates.